Skip to main content
Log in

High-dosage ustekinumab for the treatment of severe hidradenitis suppurativa

  • Correspondence
  • Published:
European Journal of Dermatology

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Martin-Ezquerra G, Masferrer E, Masferrer-Niubò M, et al. Use of biological treatments in patients with hydradenitis suppurativa. J Eur Acad Dermatol Venereol 2015; 29: 56–60.

    Article  CAS  Google Scholar 

  2. Scholl L, Hessam S, Bergmann U, Bechara FG. Surgical treatment of sinus tracts and fistulas in perianal hydradenitis suppurativa. J Cutan Med Surg 2018; 22: 239–41.

    Article  Google Scholar 

  3. Schlapbach C, Hänni T, Yawalkar N, Hunger RE. Expression of the IL-23/Th17 pathway in lesions of hydradenitis suppurativa. J Am Acad Dermatol 2011; 65: 790–8.

    Article  CAS  Google Scholar 

  4. Blok JL, Li K, Brodmerkel C, Horvátovich P, Jonkman MF, Horváth B. Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. Br J Dermatol 2016; 174: 839–46.

    Article  CAS  Google Scholar 

  5. Gulliver WP, Jemec GB, Baker KA. Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa. J Eur Acad Dermatol Venereol 2012; 26: 911–4.

    Article  CAS  Google Scholar 

  6. Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as induction and maintenance therapy for Crohn’s disease. N Engl J Med 2016; 375: 1946–60.

    Article  CAS  Google Scholar 

  7. Bechara FG. MIBHS: a concept to distinguish between medical and surgical treatment in hidradenitis suppurativa. Exp Dermatol 2016; 25: 8.

    Google Scholar 

  8. Hessam S, Scholl L, Sand M, Schmitz L, Reitenbach S, Bechara FG. A novel severity assessment scoring system for hidradenitis suppurativa. JAMA Dermatol 2018; 154: 330–5.

    Article  Google Scholar 

  9. McPhie ML, Bridgman AC, Kirchhof MG. Combination therapies for hidradenitis suppurativa: a retrospective chart review of 31 patients. J Cutan Med Surg 2019; 23: 270–6.

    Article  CAS  Google Scholar 

  10. Frew JW. Assessing the efficacy of new biologic therapies in hidradenitis suppurativa: consistency vs. bias in outcome measures in moderate and severe disease. J Eur Acad Dermatol Venereol 2019; 33: e298–300.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Falk G. Bechara.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Scholl, L., Hessam, S., Garcovich, S. et al. High-dosage ustekinumab for the treatment of severe hidradenitis suppurativa. Eur J Dermatol 29, 659–661 (2019). https://doi.org/10.1684/ejd.2019.3663

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3663

Navigation